Goal Reached Thanks to every supporter — we hit 100%!

Goal: 1000 CNY · Raised: 1000 CNY

100.0%
Get alerts for future matching vulnerabilitiesLog in to subscribe
I. Basic Information for CVE-2023-34835
Vulnerability Information

Have questions about the vulnerability? See if Shenlong's analysis helps!
View Shenlong Deep Dive ↗

Although we use advanced large model technology, its output may still contain inaccurate or outdated information.Shenlong tries to ensure data accuracy, but please verify and judge based on the actual situation.

Vulnerability Title
N/A
Source: NVD (National Vulnerability Database)
Vulnerability Description
A Cross Site Scripting vulnerability in Microworld Technologies eScan Management console v.14.0.1400.2281 allows a remote attacker to execute arbitrary JavaScript code via a vulnerable delete_file parameter.
Source: NVD (National Vulnerability Database)
CVSS Information
N/A
Source: NVD (National Vulnerability Database)
Vulnerability Type
N/A
Source: NVD (National Vulnerability Database)
Vulnerability Title
MicroWorld Technologies eScan Management Console 跨站脚本漏洞
Source: CNNVD (China National Vulnerability Database)
Vulnerability Description
MicroWorld Technologies eScan Management Console是美国MicroWorld Technologies公司的一个电子扫描管理控制台。 Microworld Technologies eScan Management console v.14.0.1400.2281版本存在跨站脚本漏洞,该漏洞源于允许远程攻击者通过易受攻击的 delete_file 参数执行任意 JavaScript 代码。
Source: CNNVD (China National Vulnerability Database)
CVSS Information
N/A
Source: CNNVD (China National Vulnerability Database)
Vulnerability Type
N/A
Source: CNNVD (China National Vulnerability Database)
Affected Products
VendorProductAffected VersionsCPESubscribe
-n/a n/a -
II. Public POCs for CVE-2023-34835
#POC DescriptionSource LinkShenlong Link
1Nonehttps://github.com/sahiloj/CVE-2023-34835POC Details
AI-Generated POCPremium

No public POC found.

Login to generate AI POC
III. Intelligence Information for CVE-2023-34835
Please Login to view more intelligence information
IV. Related Vulnerabilities
V. Comments for CVE-2023-34835

No comments yet


Leave a comment